相关实验视频
Updated: Jul 2, 2026

08:57
Aip1p Dynamics Are Altered by the R256H Mutation in Actin
Published on: July 30, 2014
8.1K
通过ARTP突变和发酵优化改善fidaxomicin的生产在Actinoplanes和Deccanensis中
Jing-Yi Ruan1, Huang Xie1, Yi-Lei Zheng1
1First Affiliated Hospital and Institute of Pharmaceutical Biotechnology, Zhejiang University School of Medicine, Hangzhou, China.
Synthetic and systems biotechnology
|June 30, 2025
概括
研究人员提高了fidaxomicin的产量,用于治疗困难菌感染 (CDI). 他们在15L发酵器中实现了创纪录的3.9g/L产量,为工业抗生素制造铺平了道路.
科学领域:
- 微生物学 微生物学
- 生物技术是生物技术.
- 发酵科学 发酵科学
背景情况:
- 菲达克索米辛是治疗Clostridioides difficile (CDI) 感染的关键抗生素,其疗效优于万科米辛和美트로尼达.
- 低发酵产量目前限制了fidaxomicin的大规模工业生产,这对广泛的可用性构成了挑战.
研究的目的:
- 为了显著提高fidaxomicin生产产量在Actinoplanes deccanensis.
- 为fidaxomicin建立一个可扩展和工业上可行的发酵过程.
主要方法:
- 通过过度表达调节因子fadR1,对Actinoplanes deccanensis OE-R1/WT进行遗传修饰.
- 使用kanR/gusA双报告器系统和ARTP突变发生的高产量突变的查.
- 代谢工程通过过度表达甲基转移酶和优化发酵条件,包括基质补充和扩大规模.
主要成果:
- 开发了一种高产品种PA-13,增加了fidaxomicin的产量5.5倍,达到757.34 mg/L.
- 进一步的遗传和工艺优化使得产量达到929.17 mg/L,并减少了副产品的形成.
- 在15L发酵器中获得了3949.05 mg/L (3.9 g/L) 的最终产量,这是创纪录的.
结论:
- 这项研究成功地建立了一个强大的,高产量的发酵过程,用于fidaxomicin,在15L发酵器中超过3.9g/L.
- 这些发现为工业规模生产fidaxomicin提供了坚实的基础,并为改善其他actinomycetes产量提供了洞察力.
相关概念视频
Bioreactor Controls-III
Strain improvement is a foundational strategy in industrial microbiology aimed at maximizing microbial productivity, particularly because natural isolates typically yield commercially valuable products in very low concentrations. Although optimizing the culture medium and environmental conditions can improve yields, these adjustments are inherently limited by the organism’s genetic potential. As a result, the focus shifts toward genetic modifications to enhance biosynthetic capacity. The...
Scale-Up Processes
The scale-up of microbial fermentation processes is essential in industrial biotechnology, allowing the transition from laboratory-scale experiments to commercial-scale production while aiming to maintain product yield and quality. This process requires meticulous adjustment of equipment design, process parameters, and contamination control strategies to accommodate increasing culture volumes.At the laboratory scale, cultures are typically maintained in 1 to 10-liter glass or autoclavable...
Upstream Processing
Upstream processing represents a critical phase in biomanufacturing, wherein biological systems such as microorganisms, mammalian cells, or insect cells are cultivated to produce therapeutic proteins, vaccines, enzymes, or other biologically derived products. This phase encompasses all steps from the selection and genetic manipulation of the production organism to the cultivation of cells in bioreactors under tightly controlled environmental conditions.Host Selection and Genetic OptimizationThe...
Production of Antibiotics
Penicillin, one of the earliest and most widely used antibiotics, is produced industrially by the filamentous fungus Penicillium chrysogenum. Large stirred-tank bioreactors ranging from tens to hundreds of thousands of liters maintain tightly controlled temperature, pH, and dissolved oxygen conditions to support fungal metabolism and maximize antibiotic yield. Penicillin is a secondary metabolite, synthesized primarily during the stationary growth phase, which requires a carefully managed...
Production of Pharmaceuticals
Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under sterile, tightly...

